Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice
- PMID: 606433
- PMCID: PMC1541173
Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice
Abstract
The course of infection with Leishmania donovani was followed in seven strains of laboratory mice with measurement of the liver parasite burdens over 20 weeks. The acute parasite population growth rate varied greatly between, but not within, strains. Four strains were relatively resistant with less than an eight-fold increase while the three acutely susceptible strains showed over an eight-fold increase in the first month. Thereafter, one initially susceptible strain showed a dramatic fall in parasite numbers with histological liver damage while another strain maintained an immense parasite load for up to 2 years involving mononuclear phagocytes throughout the body. The system provides a model for studying genetic control of resistance to intracellular infection and the range of responses is compared with human leprosy and cutaneous leishmaniasis.
Similar articles
-
Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.Clin Exp Immunol. 1980 Jun;40(3):508-14. Clin Exp Immunol. 1980. PMID: 6968259 Free PMC article.
-
IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.Eur J Immunol. 2000 Mar;30(3):834-9. doi: 10.1002/1521-4141(200003)30:3<834::AID-IMMU834>3.0.CO;2-9. Eur J Immunol. 2000. PMID: 10741399
-
Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.Clin Exp Immunol. 1977 Oct;30(1):130-40. Clin Exp Immunol. 1977. PMID: 606434 Free PMC article.
-
The immunopathology of experimental visceral leishmaniasis.Immunol Rev. 2004 Oct;201:239-53. doi: 10.1111/j.0105-2896.2004.00188.x. Immunol Rev. 2004. PMID: 15361245 Review.
-
Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis.Trends Parasitol. 2004 Nov;20(11):524-30. doi: 10.1016/j.pt.2004.08.009. Trends Parasitol. 2004. PMID: 15471704 Review.
Cited by
-
Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis.Parasitol Res. 2013 Jun;112(6):2269-80. doi: 10.1007/s00436-013-3387-2. Epub 2013 Mar 22. Parasitol Res. 2013. PMID: 23519426
-
Immunoprophylactic Potential of a Cocktail of Three Low Molecular Weight Antigens of Leishmania donovani along with Various Adjuvants Against Experimental Visceral leishmaniasis.Iran J Parasitol. 2018 Jan-Mar;13(1):11-23. Iran J Parasitol. 2018. PMID: 29963081 Free PMC article.
-
Visceral leishmaniasis in the BALB/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin B.Antimicrob Agents Chemother. 1998 Oct;42(10):2722-5. doi: 10.1128/AAC.42.10.2722. Antimicrob Agents Chemother. 1998. PMID: 9756784 Free PMC article.
-
Transfer of innate resistance and susceptibility to Leishmania donovani infection in mouse radiation bone marrow chimaeras.Immunology. 1984 Jul;52(3):417-22. Immunology. 1984. PMID: 6378765 Free PMC article.
-
Single gene control of resistance to cutaneous leishmaniasis in mice.Immunogenetics. 1981;14(1-2):29-39. doi: 10.1007/BF00344297. Immunogenetics. 1981. PMID: 7327625
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources